EUVIMEDEUVIMED entdecken
Crossref

Clearance of NNRTI resistance-associated mutations in the HIV-1 DNA reservoir with or without the presence of M184V mutation

Cathia Soulie iD, Karen Zafilaza, Marc Wirden iD, Sophie Sayon, Basma Abdi iD, Théophile Cocherie, Elisa Teyssou, Marc-Antoine Valantin, Antoine Faycal, Luminita Schneider, Valérie Pourcher iD, Vincent Calvez und 1 weitere

Journal of Antimicrobial Chemotherapy · 02.07.2026 · 81 (8)

DOI: 10.1093/jac/dkag245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 15.07.2026. Verfasst von Cathia Soulie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière - Charles F…. Hauptthemen laut MEDLINE: HIV-1, Drug Resistance, Viral, HIV Infections, Reverse Transcriptase Inhibitors. Die Arbeit nennt 13 Literaturangaben. Gefördert von: Agence Nationale de Recherches sur le SIDA et les Hépatites virales - Maladies Infectieuses Emergentes (ANRS-MIE), Merck Sharp & Dohme (MSD), Agence Nationale de Recherches sur le SIDA et les Hépatites virales – Maladies Infectieuses Emergentes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent studies have shown progress in understanding the evolution of HIV antiretroviral resistance–associated mutations (RAMs) in the reservoir, particularly M184V, but data on non-nucleoside reverse transcriptase (RT) inhibitors RAMs (NNRTI-RAMs) remain limited. This study aimed to describe the evolution of NNRTI-RAMs in the reservoir, with or without M184V. Materials and methods This single-centre retrospective study included people living with HIV-1 (PLWHIV) who had one or more NNRTI-RAMs detected in plasma genotype, and who had blood samples collected after at least 1 year of virological suppression on antiretroviral therapy. RT NGS was performed at two time points during virological suppression: DNA1 (2019) and DNA2 (2024).

Results

Of 49 PLWHIV with NNRTI-RAMs, 40 had an M184V mutation in their previous HIV-1 RNA genotypes. At DNA1, NNRTI-RAMs and M184V were present in 44.9% (n = 22/49) and 65.0% (n = 26/40) of PLWHIV, respectively. In univariate analysis, NNRTI-RAM clearance at DNA1 was associated with shorter duration of replication under an NNRTI regimen at virological failure (VF) (5 versus 37 months, P = 0.013), longer duration between RNA and DNA1 genotypes (14 versus 9 years, P = 0.010) and older age (60 versus 55 years, P = 0.037). Only replication duration remained associated with the persistence of NNRTI-RAMs (P = 0.041) in multivariate analysis. Past M184V in RNA genotypes was not associated with NNRTI-RAM persistence at DNA1 or DNA2 (P = 0.477 and P = 0.711, respectively). No significant evolution of NNRTI-RAMs was observed between DNA1 and DNA2 (P > 0.999).

Conclusions

In virologically suppressed PLWHIV, NNRTI-RAMs and M184V in the HIV blood reservoir decreased without evidence of interaction between their evolution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Drug Resistance, ViralHIV InfectionsReverse Transcriptase InhibitorsAnti-HIV AgentsHumansRetrospective StudiesDNA, ViralMutationFemaleMaleGenotypeAdultMiddle AgedHIV Reverse TranscriptaseRNA, ViralViral Load

Substanzen

Reverse Transcriptase InhibitorsDNA, ViralAnti-HIV AgentsHIV Reverse TranscriptaseRNA, Viral

Autor:innen und Institutionen

  • Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, laboratoire de virologie, 45-83 bd de l'hôpital, Paris 75013, Fra…
  • Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, service de maladies infectieuses, Paris, France.

ORCID-Profile: Cathia Soulie, Marc Wirden, Basma Abdi, Valérie Pourcher

Förderung

  • Agence Nationale de Recherches sur le SIDA et les Hépatites virales - Maladies Infectieuses Emergentes (ANRS-MIE)
  • Merck Sharp & Dohme (MSD)
  • Agence Nationale de Recherches sur le SIDA et les Hépatites virales – Maladies Infectieuses Emergentes

Zitieren

APA

Soulie, C., Zafilaza, K., Wirden, M., Sayon, S., Abdi, B., Cocherie, T., Teyssou, E., Valantin, M. A., Faycal, A., Schneider, L., Pourcher, V., Calvez, V., & Marcelin, A. G. (2026). Clearance of NNRTI resistance-associated mutations in the HIV-1 DNA reservoir with or without the presence of M184V mutation. Journal of Antimicrobial Chemotherapy, 81(8). https://doi.org/10.1093/jac/dkag245

Vancouver

Soulie C, Zafilaza K, Wirden M, Sayon S, Abdi B, Cocherie T, et al. Clearance of NNRTI resistance-associated mutations in the HIV-1 DNA reservoir with or without the presence of M184V mutation. Journal of Antimicrobial Chemotherapy. 2026;81(8). doi:10.1093/jac/dkag245

BibTeX
@article{Soulie2026,
  author = {Soulie, Cathia and Zafilaza, Karen and Wirden, Marc and Sayon, Sophie and Abdi, Basma and Cocherie, Théophile and Teyssou, Elisa and Valantin, Marc-Antoine and Faycal, Antoine and Schneider, Luminita and Pourcher, Valérie and Calvez, Vincent and Marcelin, Anne-Geneviève},
  title = {Clearance of NNRTI resistance-associated mutations in the HIV-1 DNA reservoir with or without the presence of M184V mutation},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {8},
  doi = {10.1093/jac/dkag245}
}
Kostenlos starten →